James Molloy
Stock Analyst at Alliance Global Partners
(0.50)
# 3,829
Out of 4,829 analysts
33
Total ratings
23.53%
Success rate
-44.03%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.30 | +1,047.92% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.54 | +1,476.99% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $21.38 | +63.73% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $0.93 | +1,516.38% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $7.59 | +163.50% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $490 | $4.07 | +11,939.31% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $19.01 | +5,686.43% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.54 | +224.07% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.15 | +217.38% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $1.07 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $1.04 | +1,246.15% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.15 | +2,508.70% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.10 | +581.82% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.63 | +255.24% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.52 | +426.32% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $2.87 | +143.90% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.40 | +5,614.29% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.76 | +1,998.09% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.39 | +3,489.74% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.82 | +1,739.36% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $6.25 | +134,300.00% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.52 | +9,768.42% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.36 | +68,833.82% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.47 | +912.15% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.30
Upside: +1,047.92%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.54
Upside: +1,476.99%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $21.38
Upside: +63.73%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.93
Upside: +1,516.38%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $7.59
Upside: +163.50%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $4.07
Upside: +11,939.31%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $19.01
Upside: +5,686.43%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.54
Upside: +224.07%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.15
Upside: +217.38%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.07
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $1.04
Upside: +1,246.15%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.15
Upside: +2,508.70%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.10
Upside: +581.82%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.63
Upside: +255.24%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.52
Upside: +426.32%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $2.87
Upside: +143.90%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.40
Upside: +5,614.29%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.76
Upside: +1,998.09%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.39
Upside: +3,489.74%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.82
Upside: +1,739.36%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $6.25
Upside: +134,300.00%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $1.52
Upside: +9,768.42%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.36
Upside: +68,833.82%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.47
Upside: +912.15%